Companies › Pfizer, Inc.

Pfizer, Inc.

Company Pharma & Medical Devices

Pfizer, Inc. is listed as a company in Pharma & Medical Devices. It has filed 8 comment letters on 7 proposed federal rules in 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
8
Rules commented on
7
First letter
2026-03-31
Latest letter
2026-09-02
Agencies most often
Centers for Medicare & Medicaid Services (5); Drug Enforcement Administration (1); Office of the Secretary (1)

Activity by year

20268

Letters

2026

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-02

Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

CMS-2026-2344Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-01

Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

CMS-2026-2344Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-01

Revision of Applications for Manufacturing and Procurement Quotas

DEA-2026-0793Justice Department, Drug Enforcement Administration · filed 2026-07-21

Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges

CMS-2026-1255Health and Human Services Department, Centers for Medicare & Medicaid Services, Office of the Secretary · filed 2026-06-29 · filed as “Pfizer.”

Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027

CMS-2026-1321Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-06-02 · filed as “Pfizer Inc.”

Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

HHSIG-2026-0001Health and Human Services Department, Inspector General Office, Health and Human Services Department · filed 2026-04-02

Medicare Program; Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals

CMS-2026-0298Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-03-31 · filed as “Pfizer”